Fter FXR activation was nevertheless apparent in SR-BI deficient cells (Fig.
Fter FXR activation was still apparent in SR-BI deficient cells (Fig. 6) and was presumably mediated by impaired CD36 expression and function just after bile acid therapy (Fig. 7). Like…